GENPF (Genix Pharmaceuticals) FCF Yield %: -9.91 (As of Jul. 01, 2026)


What is Genix Pharmaceuticals FCF Yield %?

Genix Pharmaceuticals GENPF FCF Yield % is -9.91 as of Jul. 01, 2026. The stock has 3 warning signs investors should review. Among 1,001 Drug Manufacturers companies, Genix Pharmaceuticals ranks worse than 81.12% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Genix Pharmaceuticals's Trailing 12-Month Free Cash Flow is $-0.07 Mil, and Market Cap is $0.65 Mil. Therefore, Genix Pharmaceuticals's FCF Yield % for today is -9.91%.

The historical rank and industry rank for Genix Pharmaceuticals's FCF Yield % or its related term are showing as below:

GENPF' s FCF Yield % Range Over the Past 10 Years
Min: -26.32   Med: -1.9   Max: 2.36
Current: -9.91


During the past 13 years, the highest FCF Yield % of Genix Pharmaceuticals was 2.36%. The lowest was -26.32%. And the median was -1.90%.

GENPF's FCF Yield % is ranked worse than
81.12% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 0.65 vs GENPF: -9.91

Genix Pharmaceuticals's FCF Margin % for the quarter that ended in Jan. 2026 was 0.00%.


Genix Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Genix Pharmaceuticals FCF Yield % Related Terms


Genix Pharmaceuticals FCF Yield % Historical Data

* Premium members only.

The historical data trend for Genix Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genix Pharmaceuticals FCF Yield % Chart

Genix Pharmaceuticals Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.84 -34.40 -9.06 -5.74 -8.35

Genix Pharmaceuticals Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.43 -1.69 -5.87 -8.26 -10.19

GENPF vs ZTS, UTHR: FCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Genix Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genix Pharmaceuticals FCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genix Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Genix Pharmaceuticals's FCF Yield % falls into.



Genix Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Genix Pharmaceuticals's FCF Yield % for the fiscal year that ended in Oct. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.089 / 1.0652976
=-8.35%

Genix Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Jan. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.022 * 4 / 0.8632584
=-10.19%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -9.91 mean?
Genix Pharmaceuticals (GENPF) has a FCF Yield % of -9.91 as of Jul. 01, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Genix Pharmaceuticals and its competitors. According to the industry distribution chart, Genix Pharmaceuticals ranks #812 out of 1001 companies in the Drug Manufacturers industry, placing it in the top 81.1%.
Is Genix Pharmaceuticals' FCF Yield % too high?
Genix Pharmaceuticals' current FCF Yield % is -9.91. Based on the distribution chart, Genix Pharmaceuticals ranks #812 out of 1001 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Genix Pharmaceuticals' FCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Genix Pharmaceuticals ranks #812 out of 1001 companies for FCF Yield %. This places Genix Pharmaceuticals in the lower half of its industry. The industry median FCF Yield % is 0.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.65, based on 1,001 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Genix Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genix Pharmaceuticals's current FCF Yield % is -9.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genix Pharmaceuticals stock overvalued right now?
Genix Pharmaceuticals (GENPF) has a current FCF Yield % of -9.91. The current FCF Yield % is -9.91. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Genix Pharmaceuticals (GENPF), the current FCF Yield % is -9.91 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genix Pharmaceuticals Business Description

Other Exchanges GENX:Canada
Address 1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically the company operates only in Canada.